Regulatory interplay between microRNAs and WNT pathway in glioma

Peyman Tabnak1, Asrin Mafakheri2, Zanyar Haji Emsailpoor1

  • 1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

This review explores microRNAs (miRNAs) and their role in the WNT pathway in glioma, a challenging brain cancer. Understanding this interplay offers new therapeutic strategies for glioma treatment.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Glioma, a prevalent central nervous system neoplasm, exhibits poor patient survival rates.
  • Identifying molecular mechanisms driving glioma malignancy is crucial due to treatment challenges.
  • Altered microRNA (miRNA) expression is a hallmark of many cancers, including glioma.

Purpose of the Study:

  • To comprehensively review microRNAs (miRNAs) involved in the WNT pathway in glioma.
  • To elucidate the interplay between miRNAs and the WNT pathway in glioma progression.
  • To highlight potential therapeutic targets based on miRNA-WNT pathway interactions.

Main Methods:

  • Literature review of studies on miRNAs, WNT pathway, and glioma.
  • Analysis of miRNA involvement in key cancer processes within glioma.
  • Examination of therapeutic strategies targeting the miRNA-WNT axis.

Main Results:

  • MicroRNAs (miRNAs) significantly influence WNT pathway activity in glioma.
  • The interplay between miRNAs and WNT signaling regulates glioma proliferation, invasion, migration, and treatment resistance.
  • Specific miRNAs and WNT pathway components are implicated in epithelial-mesenchymal transition in glioma.

Conclusions:

  • The intricate relationship between miRNAs and the WNT pathway is central to glioma pathogenesis.
  • Targeting this miRNA-WNT axis presents promising avenues for novel glioma therapies.
  • Further research into these interactions could lead to improved treatment outcomes for glioma patients.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K